Pharmafile Logo
Pharmafocus logo
Advanced Search

Fourth-dose COVID-19 jab demonstrates good boost

May 10, 2022
Manufacturing and Production

A UK trial has revealed that fourth-dose COVID-19 booster vaccines increase protection against the disease, particularly those aged over 70. …

News

NIH discovery could advance precise therapies for blinding diseases

May 10, 2022
Manufacturing and Production

Research at the National Institutes of Health (NIH) have identified distinct differences among the cells comprising a tissue in the …

News

Evofem’s Phase III trial reveals fewer UTIs in women using Phexxi

May 9, 2022
Sales and Marketing

Evofem has announced new data from the Phase III AMPOWER clinical trial of Phexxi (lactic acid, citric acid, and potassium …

News

NIH launches clinical trial of vaccine for Epstein-Barr virus

May 9, 2022
Research and Development

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched an …

News

FDA places partial clinical hold on BioCryst’s lead candidate, BCX9930

May 9, 2022
Sales and Marketing

The FDA has imposed a partial clinical hold on BioCryst’s Factor D inhibitor, BCX9930. The clinical hold arrives around a …

News

Case of monkeypox confirmed in England

May 9, 2022
Sales and Marketing

The UK Health Security Agency has confirmed that a person in England has been diagnosed with the monkeypox virus.The patient …

News
san

Shabir Hasham

May 6, 2022

Shabir Hasham has served as Santhera’s Global Development Program Lead & Global Head Medical Affairs for the past three years, …

Appointment
san

Shabir Hasham

May 6, 2022

Shabir Hasham has served as Santhera’s Global Development Program Lead & Global Head Medical Affairs for the past three years, …

Appointment

Allison Williamson

May 6, 2022

BIOCAPTIVA has announced the appointment of Alison Williamson as Chief Financial Officer, and member of the board.Alison has over 30 …

Appointment
richard_laxer

Richard Laxer

May 6, 2022

Richard Laxer joins Oxford Science Enterprises as an independent non-executive director. Richard is a veteran of GE Capital, serving the …

Appointment
karen_mullen_boyds

Dr Karen Mullen

May 6, 2022

Dr Karen Mullen joins Boyds from GlaxoSmithKline, where, as Country Medical Director for UK and Ireland, she led and managed …

Appointment
karen_mullen_boyds

Dr Karen Mullen

May 6, 2022

 

Appointment

Appy Days: How the smartphone app is revolutionising mental healthcare

May 6, 2022

Over the last decade, our individual awareness and understanding of mental health has risen to unprecedented levels. Despite its pitfalls, …

Feature

WHO launches first ever global report on Infection Prevention and Control

May 6, 2022
Medical Communications

A new report from WHO has highlighted the importance of effective IPC programmes, and shown that where good hand hygiene …

News

Open Orphan to begin first-ever COVID-19 challenge trial

May 6, 2022
Medical Communications

Open Orphan has been appointed by an unnamed existing “big pharma” client to host a Phase II field study of …

News

FDA narrows use of J&J vaccine due to blood clot risk

May 6, 2022
Medical Communications

The FDA has limited the use of Johnson & Johnson’s coronavirus vaccine, to adults who cannot, or refuse to get, …

News

AstraZeneca’s heart disease drug meets key endpoints in Phase III

May 6, 2022
Medical Communications

AstraZeneca’s treatment for heart disease has delivered positive high-level results from its Phase III DELIVER trial.Farxiga (dapagliflozin) is already approved …

News

First regenerative cell therapy for hearing loss

May 5, 2022
Business Services

Rinri Therapeutics have announced the MHRA has awarded an innovation passport to the company’s lead candidate, Rincell-1. Rincell-1 is a …

News

Nearly three million people receive lifesaving NHS cancer checks

May 5, 2022
Business Services

A record three million people received vital NHS cancer tests from March 2021 to February 2022, compared to 2.4 million …

News

Health experts report more symptoms of long COVID-19

May 5, 2022
Business Services

According to health experts, many COVID-19 patients are still suffering the effects of the condition months after they first started …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025